Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of Tuesday, October 6, 2026.
NET PROFIT MARGIN
N/A
ADARx Pharmaceuticals, Inc.
Market Cap
$1.88B
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.86B
Net Profit Margin
14.72%
TTM Avg
14.79%
3Y Avg
10.03%
5Y Avg
8.07%
Market Cap
$1.93B
Net Profit Margin
3.81%
TTM Avg
9.82%
3Y Avg
11.83%
5Y Avg
11.83%
Market Cap
$1.99B
Net Profit Margin
-1.42%
TTM Avg
0.32%
3Y Avg
2.85%
5Y Avg
4.67%
Market Cap
$2.03B
Net Profit Margin
-3.11%
TTM Avg
-3.11%
3Y Avg
-3.11%
5Y Avg
-3.11%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ADARx Pharmaceuticals, Inc. (ADRX) | $1.88B | N/A | N/A | N/A | N/A |
| Enerpac Tool Group Corp. (EPAC)vs › | $1.86B | 14.72% | 14.79% | 10.03% | 8.07% |
| Cimpress plc (CMPR)vs › | $1.85B | 2.57% | 1.50% | 0.56% | -0.49% |
| Midera Food Processing, Inc. (MFP)vs › | $1.93B | 3.81% | 9.82% | 11.83% | 11.83% |
| Neutron Holdings, Inc. (LIME)vs › | $1.80B | N/A | N/A | N/A | N/A |
| Werner Enterprises, Inc. (WERN)vs › | $1.99B | -1.42% | 0.32% | 2.85% | 4.67% |
| Allient Inc. (ALNT)vs › | $2.03B | 4.98% | 3.23% | 3.52% | 3.96% |
| Arxis, Inc. Class A Common Stock (ARXS)vs › | $2.03B | -3.11% | -3.11% | -3.11% | -3.11% |
| Hub Group, Inc. (HUBG)vs › | $1.71B | 2.82% | 3.32% | 4.34% | 3.73% |
| Preformed Line Products Company (PLPC)vs › | $2.07B | 5.82% | 5.76% | 7.38% | 7.14% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
